D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
NARI holding history
Inari Medical, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NARI overviewAll 13F holders of NARIFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −12,491−100.0% | Sold out | Holders |
| Q4 2024 | 12,491 | $637.7K | <0.1% | +892+7.7% | Added | Holders |
| Q3 2024 | 11,599 | $478.3K | <0.1% | +143+1.2% | Added | Holders |
| Q2 2024 | 11,456 | $551.6K | <0.1% | +695+6.5% | Added | Holders |
| Q1 2024 | 10,761 | $516.3K | <0.1% | +191+1.8% | Added | Holders |
| Q4 2023 | 10,570 | $686.2K | <0.1% | +188+1.8% | Added | Holders |
| Q3 2023 | 10,382 | $679.0K | <0.1% | +3,296+46.5% | Added | Holders |
| Q2 2023 | 7,086 | $412.0K | <0.1% | +49+0.7% | Added | Holders |
| Q1 2023 | 7,037 | $434.5K | <0.1% | −417−5.6% | Reduced | Holders |
| Q4 2022 | 7,454 | $473.8K | <0.1% | −60−0.8% | Reduced | Holders |
| Q3 2022 | 7,514 | $546.0K | <0.1% | +417+5.9% | Added | Holders |
| Q2 2022 | 7,097 | $483.0K | <0.1% | +160+2.3% | Added | Holders |
| Q1 2022 | 6,937 | $629.0K | <0.1% | +24+0.3% | Added | Holders |
| Q4 2021 | 6,913 | $631.0K | <0.1% | +392+6.0% | Added | Holders |
| Q3 2021 | 6,521 | $529.0K | <0.1% | +546+9.1% | Added | Holders |
| Q2 2021 | 5,975 | $557.0K | <0.1% | +295+5.2% | Added | Holders |
| Q1 2021 | 5,680 | $608.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.